Authors : Asmae Bentaleb; Khaoula Laaboub; Mohamed Amine Zouaki; Monir Charit; Nehad Mohamed Alali; Nabil Elachhab; Rajae Tachinante; Fatima Elhassouni

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/y52b36j9

Scribd : https://tinyurl.com/yc2wxf56

DOI : https://doi.org/10.38124/ijisrt/25aug196

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Peripartum cardiomyopathy (PPCM) represents a rare etiology of heart failure manifesting in women during the late gestational period or early postpartum phase. Despite several proposed pathophysiological mechanisms, the precise etiology of PPCM remains elusive, with current evidence supporting a multifactorial origin. Multiple definitions have been established to characterize this distinct clinical entity. Acute heart failure management in PPCM aligns with standard heart failure protocols, adjusted for pregnancy-specific risks. Early delivery is reserved for maternal or fetal compromise. Given the high recurrence risk, thorough contraceptive counseling is imperative. Prognosis is generally favorable, with >50% of patients achieving spontaneous LV function recovery within six months postpartum. The management of peripartum cardiomyopathy presents significant anesthetic and obstetric challenges, particularly in complicated cases, highlighting the complexity of perioperative care in such critical conditions.

Keywords : Peripartum Cardiomyopathy, Morbid Obesity, Chronic Hypertension, High-Risk Pregnancy, Anesthetic Management.

References :

1. Sliwa K, Hilfiker‐Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure. 2014;12(8):767-78.
2. Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum Cardiomyopathy: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020;75(2):207-21.
3. Bello N, Rendon ISH, Arany Z. The Relationship Between Pre-Eclampsia and Peripartum Cardiomyopathy. Journal of the American College of Cardiology. 2013;62(18):1715-23.
4. Guglielminotti J, Landau R, Li G. Major Neurologic Complications Associated With Postdural Puncture Headache in Obstetrics: A Retrospective Cohort Study. Anesthesia & Analgesia. 2019;129(5):1328-36.
5. Nayak A, Ninave S, Tayade S, Tayade H. Anesthetic Management in Peripartum Cardiomyopathy: A Contemporary Review. Cureus. 2022.
6. Sigauke FR, Ntsinjana H, Tsabedze N. Peripartum cardiomyopathy: a comprehensive and contemporary review. Heart Fail Rev. 2024;29(6):1261-78.
7. Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765-8.
8. Mandviwala T, Khalid U, Deswal A. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker? Current Atherosclerosis Reports. 2016;18(5).
9. Shrikhande L, Shrikhande A, Shrikhande B. Peripartum Cardiomyopathy. J Obstet Gynaecol India. 2022;72(5):377-81.
10. Ersboll AS, Damm P, Gustafsson F, Vejlstrup NG, Johansen M. Peripartum cardiomyopathy: a systematic literature review. Acta Obstet Gynecol Scand. 2016;95(11):1205-19.
11. Aydın N, Akıllı H, Alsancak Y, Tatar S. Dilated Cardiomyopathy in Pregnancy: A Review of ACEI Exposure and Fetal Risks. International Journal of the Cardiovascular Academy. 2024:79-81.
12. Jackson AM, Bauersachs J, Petrie MC, van der Meer P, Laroche C, Farhan HA, et al. Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry. European Journal of Heart Failure. 2023;26(1):34-42.